Emerging Infectious Diseases (Mar 2022)

Ebola Virus Glycoprotein IgG Seroprevalence in Community Previously Affected by Ebola, Sierra Leone

  • Daniela Manno,
  • Philip Ayieko,
  • David Ishola,
  • Muhammed O. Afolabi,
  • Baimba Rogers,
  • Frank Baiden,
  • Alimamy Serry-Bangura,
  • Osman M. Bah,
  • Brian Köhn,
  • Ibrahim Swaray,
  • Kwabena Owusu-Kyei,
  • Godfrey T. Otieno,
  • Dickens Kowuor,
  • Daniel Tindanbil,
  • Elizabeth Smout,
  • Cynthia Robinson,
  • Babajide Keshinro,
  • Julie Foster,
  • Katherine Gallagher,
  • Brett Lowe,
  • Macaya Douoguih,
  • Bailah Leigh,
  • Brian Greenwood,
  • Deborah Watson-Jones

DOI
https://doi.org/10.3201/eid2803.211496
Journal volume & issue
Vol. 28, no. 3
pp. 734 – 738

Abstract

Read online

We explored the association of Ebola virus antibody seropositivity and concentration with potential risk factors for infection. Among 1,282 adults and children from a community affected by the 2014–2016 Ebola outbreak in Sierra Leone, 8% were seropositive for virus antibodies but never experienced disease symptoms. Antibody concentration increased with age.

Keywords